Gregory Norden
Director · Praxis Precision Medicines, Inc.
- 2025
- Jun 12, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregory Norden files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Terrance P. Coyne - $33.61M in RPRX purchases and sales in the last 12 months
- Adage Capital Management, L.P. - $33.20M in PRAX purchases and sales in the last 12 months
- Christopher Hite - $27.36M in RPRX purchases and sales in the last 12 months
- George W. Lloyd - $9.57M in RPRX purchases and sales in the last 12 months
- Marshall Urist - $7.01M in RPRX purchases and sales in the last 12 months
- Alex Nemiroff - $4.85M in PRAX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregory Norden?
Gregory Norden is a corporate insider, tracked as Director of Praxis Precision Medicines, Inc. (PRAX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Gregory Norden last file a Form 4?
The most recent primary Form 4 on record is dated 12 June 2026, one of 7 filings going back to 2025.
Has Gregory Norden been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.38M) across all tracked filings.
